Antiviral drugs transformed the treatment of infections caused by HIV, HBV, HCV and herpesviruses. For many other (often neglected and life‑threatening) viral diseases, such drugs are not available. Broader-acting antiviral drugs (ideally spanning entire viral families) will also be a critical pillar of epi- and pandemic preparedness. I will present our approach to develop novel antiviral strategies and drugs. As one of the examples, I will discuss the discovery and development of Mosnodenvir, the first antiviral drug to show activity against dengue in humans. [suggested reading : Kaptein et al., Nature. (2021) 598:504-509 ; Laporte et al., Nature (2025) 640 :514-52]
Johan Neyts research is focused on the development of antiviral strategies and antiviral drugs against endemic, emerging and neglected viral infections. He is responsible for the Belgian VirusBankPlatform, where tools and models for epidemic and pandemic preparedness are developed. He is past-president of the International Society for Antiviral Research, scientific advisor of multiple (inter)national organizations. He published ~700 scientific papers, received multiple (inter)national awards and gave hundreds of invited lectures as well as interviews to lay-press.
Moderation: Professorin Dr. Christa Kühn
-------
Organizational information
The Alfried Krupp Wissenschaftskolleg is offering this event live as a zoom meeting in which viewers can participate in writing via chat.
- We would be pleased if you provided your clear name when dialing into Zoom. Of course, you can also take part in the event under a pseudonym.
- A list of all participants can be viewed by all those involved throughout the event.
- During the lecture, the microphones of the spectators are all automatically muted so that no disturbing background noise is generated. You are welcome to turn on the camera of the spectators during the lecture.
- During the entire event, requests to speak or questions can be asked in writing in the chat.
Recording of the digital lecture
The digital lecture will be recorded for use in the college's media library. Only the speaker, his/her presentation and the moderator will be heard or seen in the recording. Video, audio or chat contributions are not recorded. A "REC" sign at the edge of the picture informs the participants.